Clinical trial
Pediatric Epilepsy Study in Subjects 1-24 Months
NCT00044278 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00044278 |
|---|---|
| Title | Pediatric Epilepsy Study in Subjects 1-24 Months |
| Official title | An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | lamotrigine |
| Enrollment | 197 |
| Start date | Sep 1, 2000 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Aug 26, 2002 |
| Last update posted | Jan 18, 2017 |
| Countries | Argentina, Australia, Estonia, France, Hungary, Italy, Latvia, Lebanon, Lithuania, Netherlands, Portugal, Puerto Rico and 3 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: